Synthesis and biological activity of a novel 11a-homo (cyclohexyl) prostaglandin

J Med Chem. 2000 Sep 7;43(18):3400-7. doi: 10.1021/jm990587w.

Abstract

The racemic cyclohexane-for-cyclopentane ring substitution analogue of the potent prostaglandin FP agonist cloprostenol (7) was synthesized from cyclohexenediol 11 in 21 steps and 0.07% yield. In a prostaglandin FP receptor-linked second-messenger assay, racemic analogue 7 exhibited an EC(50) value of 319 nM (72% response relative to cloprostenol); the corresponding values for PGF(2)(alpha) and cloprostenol were 23 nM (91% relative response) and 1 nM (defined as 100% response), respectively. Key features of the synthesis were the selective manipulation of four hydroxyl groups to direct independent elaboration of the alpha and omega chains and a new method for synthesis of aryloxy-terminated omega chains involving Horner-Emmons elongation of an aldehyde to a methyl enone, regioselective bromination adjacent to the carbonyl, and phenoxide displacement of bromide.

MeSH terms

  • 3T3 Cells
  • Animals
  • Cloprostenol / analogs & derivatives*
  • Cloprostenol / chemical synthesis*
  • Cloprostenol / chemistry
  • Cloprostenol / pharmacology
  • Corpus Luteum / metabolism
  • Female
  • In Vitro Techniques
  • Inositol Phosphates / biosynthesis
  • Ligands
  • Mice
  • Receptors, Prostaglandin / agonists*
  • Receptors, Prostaglandin / metabolism
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • 16-(3-chlorophenoxy)-9,11a,15-trihydroxy-17,18,19,20-tetranor-11a-homo-5,13-prostadienoic acid
  • Inositol Phosphates
  • Ligands
  • Receptors, Prostaglandin
  • prostaglandin F2alpha receptor
  • Cloprostenol